- CRDF Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13G Filing
Cardiff Oncology (CRDF) SC 13GTrovagene, Inc.
Filed: 15 Jun 18, 5:00pm
Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of Trovagene, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement.
Dated: June 15, 2018
Waqas Khatri | ||
Ayrton Capital LLC | ||
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | ||
By: | /s/ Waqas Khatri | |
Waqas Khatri, for himself and as the Managing Member of the Investment Manager (for itself and on behalf of the Fund) |